Vascular parkinsonism.
Identifieur interne : 001041 ( PubMed/Corpus ); précédent : 001040; suivant : 001042Vascular parkinsonism.
Auteurs : Igor Sibon ; François TisonSource :
- Current opinion in neurology [ 1350-7540 ] ; 2004.
English descriptors
- KwdEn :
- Brain (pathology), Brain (physiopathology), Cerebrovascular Circulation (physiology), Cerebrovascular Disorders (complications), Cerebrovascular Disorders (diagnosis), Cerebrovascular Disorders (pathology), Cerebrovascular Disorders (physiopathology), Diagnosis, Differential, Diagnostic Imaging, Dopamine (metabolism), Humans, Hypertension (complications), Hypertension (diagnosis), Hypertension (pathology), Hypertension (physiopathology), Oxygen Consumption (physiology), Parkinson Disease, Secondary (diagnosis), Parkinson Disease, Secondary (etiology), Parkinson Disease, Secondary (pathology), Parkinson Disease, Secondary (physiopathology), Radioligand Assay, Receptors, Dopamine D2 (metabolism).
- MESH :
- chemical , metabolism : Dopamine, Receptors, Dopamine D2.
- complications : Cerebrovascular Disorders, Hypertension.
- diagnosis : Cerebrovascular Disorders, Hypertension, Parkinson Disease, Secondary.
- etiology : Parkinson Disease, Secondary.
- pathology : Brain, Cerebrovascular Disorders, Hypertension, Parkinson Disease, Secondary.
- physiology : Cerebrovascular Circulation, Oxygen Consumption.
- physiopathology : Brain, Cerebrovascular Disorders, Hypertension, Parkinson Disease, Secondary.
- Diagnosis, Differential, Diagnostic Imaging, Humans, Radioligand Assay.
Abstract
Vascular parkinsonism is a highly controversial concept since its first description by Critchley in 1929. There is no doubt that cerebrovascular disease can cause elements of parkinsonism. However, the extent of the spectrum of vascular parkinsonism remains quite imprecise. Here we review recent epidemiological, clinical, electrophysiological, morphological and functional brain imaging and pathological studies on 'vascular parkinsonism'.
PubMed: 15090877
Links to Exploration step
pubmed:15090877Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vascular parkinsonism.</title><author><name sortKey="Sibon, Igor" sort="Sibon, Igor" uniqKey="Sibon I" first="Igor" last="Sibon">Igor Sibon</name><affiliation><nlm:affiliation>Federation of Clinical Neurosciences, CHU de Bordeaux, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15090877</idno><idno type="pmid">15090877</idno><idno type="wicri:Area/PubMed/Corpus">001041</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001041</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vascular parkinsonism.</title><author><name sortKey="Sibon, Igor" sort="Sibon, Igor" uniqKey="Sibon I" first="Igor" last="Sibon">Igor Sibon</name><affiliation><nlm:affiliation>Federation of Clinical Neurosciences, CHU de Bordeaux, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name></author></analytic><series><title level="j">Current opinion in neurology</title><idno type="ISSN">1350-7540</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (pathology)</term><term>Brain (physiopathology)</term><term>Cerebrovascular Circulation (physiology)</term><term>Cerebrovascular Disorders (complications)</term><term>Cerebrovascular Disorders (diagnosis)</term><term>Cerebrovascular Disorders (pathology)</term><term>Cerebrovascular Disorders (physiopathology)</term><term>Diagnosis, Differential</term><term>Diagnostic Imaging</term><term>Dopamine (metabolism)</term><term>Humans</term><term>Hypertension (complications)</term><term>Hypertension (diagnosis)</term><term>Hypertension (pathology)</term><term>Hypertension (physiopathology)</term><term>Oxygen Consumption (physiology)</term><term>Parkinson Disease, Secondary (diagnosis)</term><term>Parkinson Disease, Secondary (etiology)</term><term>Parkinson Disease, Secondary (pathology)</term><term>Parkinson Disease, Secondary (physiopathology)</term><term>Radioligand Assay</term><term>Receptors, Dopamine D2 (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term><term>Receptors, Dopamine D2</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cerebrovascular Disorders</term><term>Hypertension</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cerebrovascular Disorders</term><term>Hypertension</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term><term>Cerebrovascular Disorders</term><term>Hypertension</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cerebrovascular Circulation</term><term>Oxygen Consumption</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Cerebrovascular Disorders</term><term>Hypertension</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Diagnostic Imaging</term><term>Humans</term><term>Radioligand Assay</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Vascular parkinsonism is a highly controversial concept since its first description by Critchley in 1929. There is no doubt that cerebrovascular disease can cause elements of parkinsonism. However, the extent of the spectrum of vascular parkinsonism remains quite imprecise. Here we review recent epidemiological, clinical, electrophysiological, morphological and functional brain imaging and pathological studies on 'vascular parkinsonism'.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15090877</PMID><DateCreated><Year>2004</Year><Month>04</Month><Day>19</Day></DateCreated><DateCompleted><Year>2004</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1350-7540</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Current opinion in neurology</Title><ISOAbbreviation>Curr. Opin. Neurol.</ISOAbbreviation></Journal><ArticleTitle>Vascular parkinsonism.</ArticleTitle><Pagination><MedlinePgn>49-54</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Vascular parkinsonism is a highly controversial concept since its first description by Critchley in 1929. There is no doubt that cerebrovascular disease can cause elements of parkinsonism. However, the extent of the spectrum of vascular parkinsonism remains quite imprecise. Here we review recent epidemiological, clinical, electrophysiological, morphological and functional brain imaging and pathological studies on 'vascular parkinsonism'.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Epidemiological studies have demonstrated that vascular parkinsonism represents 3-5% of all cases of parkinsonism. The more specific clinical features are a history of stroke, lower body parkinsonism and poor levodopa response. Vascular risk factors are dominated by arterial hypertension, whereas others have been less evaluated. Vascular lesions within or outside the basal ganglia, unique and multiple, lacunae or territorial infarcts can be demonstrated by magnetic resonance imaging. Functional imaging of the dopaminergic pathway helps to differentiate vascular parkinsonism from idiopathic Parkinson's disease. However, none of these clinical or imaging criteria taken alone are specific for the diagnosis. A combination of convergent clinical and imaging clues are therefore necessary to improve the accuracy of the diagnosis, which is only certain when the pathology excludes underlying idiopathic Parkinson's disease.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">At present it remains unexplained why some patients develop vascular parkinsonism and others do not with the same apparent vascular lesion load. This will need further research along with the need to develop criteria to improve the accuracy of diagnosis of vascular parkinsonism. Vascular parkinsonism is also a research field on the relationships between vascular brain lesions and neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sibon</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Federation of Clinical Neurosciences, CHU de Bordeaux, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tison</LastName><ForeName>François</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Neurol</MedlineTA><NlmUniqueID>9319162</NlmUniqueID><ISSNLinking>1350-7540</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017448">Receptors, Dopamine D2</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003952" MajorTopicYN="N">Diagnostic Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010302" MajorTopicYN="N">Parkinson Disease, Secondary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011869" MajorTopicYN="N">Radioligand Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017448" MajorTopicYN="N">Receptors, Dopamine D2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>53</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>4</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>7</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>4</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15090877</ArticleId><ArticleId IdType="pii">00019052-200402000-00009</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001041 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001041 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15090877
|texte= Vascular parkinsonism.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15090877" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |